# Single and Multiple Doses of an Oral Formulation of L-Homoarginine in Healthy Human Subjects

> **NCT02675660** · PHASE1 · COMPLETED · sponsor: **Universitätsklinikum Hamburg-Eppendorf** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **DIETARY_SUPPLEMENT:** L-Homoarginine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02675660
- **Lead sponsor:** Universitätsklinikum Hamburg-Eppendorf
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-04
- **Final completion:** 2016-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02675660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02675660, "Single and Multiple Doses of an Oral Formulation of L-Homoarginine in Healthy Human Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02675660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*